Myoung Hyoun Kim
Myoung Hyoun Kim has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Dae-Weung Kim
Department of Nuclear Medicine and Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
3 shared publications - Soon-Ah Park
Wonkwang University School of Medicine
3 shared publications - Deok Su Sin
Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
2 shared publications - Min-Su Kim
Department of Physical Medicine and Rehabilitation, Chungbuk National University Hospital, Cheongju 28644, Republic of Korea
2 shared publications - Ari Chong
Department of Nuclear Medicine, Chosun University Hospital, Gwangju, Korea
1 shared publication - Byung Hyun Byun
Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea
1 shared publication
Latest Publications
- 17 April 2026
- Published by Taylor & Francis in Topics in Stroke Rehabilitation
- Vol. 33 (8) , 918-925
Prediction of type 1 complex regional pain syndrome with the presence of diaschisis in hemiplegic supratentorial stroke patients
Globally, 25% of individuals aged ≥25 years will experience a stroke during their lifetime, and more than 100 million people are currently living with the sequelae of a prior stroke.1 Among the het...
- 17 April 2026
- Published by Taylor & Francis in Topics in Stroke Rehabilitation
- Vol. 33 (8) , 918-925
Prediction of type 1 complex regional pain syndrome with the presence of diaschisis in hemiplegic supratentorial stroke patients
Globally, 25% of individuals aged ≥25 years will experience a stroke during their lifetime, and more than 100 million people are currently living with the sequelae of a prior stroke.1 Among the het...
- 26 September 2025
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 51 (7) , e451-e453
18F-PSMA-1007 and 18F-FDG PET/CT Findings of Pulmonary Tuberculosis Mimicking Malignancy
A 78-year-old man with hormone-sensitive metastatic prostate cancer underwent chest CT, which revealed a gradually enlarging pulmonary nodule in the left upper lobe, suggestive of lymphangitic metastasis. To further evaluate the lesion, both 18 F-FDG and 18 F-PSMA-1007 PET/CT were performed. The lesion showed intense FDG uptake but relatively low PSMA uptake, raising the suspicion of a primary lung malignancy. Histopathologic examination after wedge resection confirmed pulmonary tuberculosis.
- 26 September 2025
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 51 (7) , e451-e453
18F-PSMA-1007 and 18F-FDG PET/CT Findings of Pulmonary Tuberculosis Mimicking Malignancy
A 78-year-old man with hormone-sensitive metastatic prostate cancer underwent chest CT, which revealed a gradually enlarging pulmonary nodule in the left upper lobe, suggestive of lymphangitic metastasis. To further evaluate the lesion, both 18 F-FDG and 18 F-PSMA-1007 PET/CT were performed. The lesion showed intense FDG uptake but relatively low PSMA uptake, raising the suspicion of a primary lung malignancy. Histopathologic examination after wedge resection confirmed pulmonary tuberculosis.
- 5 February 2023
- Published by Wiley in Liver International
- Vol. 43 (3) , 733-734
The utility of F‐18 FDG PET/CT for diagnosis and response evaluation of hepatosplenic tuberculosis
A 77-year-old woman underwent F-18 FDG PET/CT for evaluation of fever focus. Diffuse and intense hepatosplenic uptake was noted and lymphoma or tuberculosis was proposed. Liver biopsy revealed chronic granulomatous inflammation with Langerhans-type giant cells and necrosis. A follow-up PET/CT after anti-tuberculosis treatment revealed that the hepatosplenic uptake had resolved.
- 5 February 2023
- Published by Wiley in Liver International
- Vol. 43 (3) , 733-734
The utility of F‐18 FDG PET/CT for diagnosis and response evaluation of hepatosplenic tuberculosis
A 77-year-old woman underwent F-18 FDG PET/CT for evaluation of fever focus. Diffuse and intense hepatosplenic uptake was noted and lymphoma or tuberculosis was proposed. Liver biopsy revealed chronic granulomatous inflammation with Langerhans-type giant cells and necrosis. A follow-up PET/CT after anti-tuberculosis treatment revealed that the hepatosplenic uptake had resolved.
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Cardiovascular Imaging
- Vol. 31 (4) , 214-216
Bone SPECT/CT Findings of Complications Resulting From Cardiopulmonary Resuscitation With Defibrillation
Kim MH, et al. J Cardiovasc Imaging. 2023 May;31:e25. https://doi.org/10.4250/jcvi.2023.0016
- 1 January 2023
- Published by XMLink in Journal of Cardiovascular Imaging
- Vol. 31 (4) , 214-216
Open AccessBone SPECT/CT Findings of Complications Resulting From Cardiopulmonary Resuscitation With Defibrillation
Kim MH, et al. J Cardiovasc Imaging. 2023 May;31:e25. https://doi.org/10.4250/jcvi.2023.0016
- Open Access
- 23 August 2021
- Published by Springer Nature in Nuclear Medicine and Molecular Imaging
- Vol. 55 (5) , 203-209
KSNM60 in Non-thyroidal Radionuclide Therapy: Leaping into the Future
This year, the Korean Society of Nuclear Medicine (KSNM) is celebrating its 60th anniversary. Treatment, as well as diagnosis, has played a very important role in the development of nuclear medicine. Since I-131 was used for thyroid therapy in 1959, other radionuclide therapy is still being used, and attempts to use new radionuclide are increasing. In this review, we briefly summarize and introduce the therapies such as radioimmunotherapy, transarterial radioembolization, radionuclide therapy for neuroendocrine tumors, peptide receptor radionuclide therapy, control of metastatic bone pain, radiation synovectomy, radionuclide brachytherapy, alpha particle therapy, and boron neutron capture therapy, which has been being attempted so far in the field of nuclear medicine.
- 23 August 2021
- Published by Springer Nature in Nuclear Medicine and Molecular Imaging
- Vol. 55 (5) , 203-209
Open AccessKSNM60 in Non-thyroidal Radionuclide Therapy: Leaping into the Future
This year, the Korean Society of Nuclear Medicine (KSNM) is celebrating its 60th anniversary. Treatment, as well as diagnosis, has played a very important role in the development of nuclear medicine. Since I-131 was used for thyroid therapy in 1959, other radionuclide therapy is still being used, and attempts to use new radionuclide are increasing. In this review, we briefly summarize and introduce the therapies such as radioimmunotherapy, transarterial radioembolization, radionuclide therapy for neuroendocrine tumors, peptide receptor radionuclide therapy, control of metastatic bone pain, radiation synovectomy, radionuclide brachytherapy, alpha particle therapy, and boron neutron capture therapy, which has been being attempted so far in the field of nuclear medicine.
- 29 June 2021
- Published by Wiley in Clinical Endocrinology
- Vol. 95 (6) , 901-908
Clinical impact of radioactive iodine dose selection based on the number of metastatic lymph nodes in patients with papillary thyroid carcinoma: A multicenter retrospective cohort study
Objective: The aim of this study is to investigate whether the number of metastatic lymph nodes (LNs) could be used as a basis in the radioactive iodine (RAI) dose selection for patients with papillary thyroid carcinoma (PTC).Patients: A total of 595 patients with PTC who received first RAI therapy after total or near‐total thyroidectomy and had no evidence of disease in treatment response assessment were retrospectively enroled from five hospitals. The patients were classified into two subgroups based on the number of metastatic LNs (>5). The multivariate Cox‐proportional hazard model was performed to identify the significant factors for recurrence prediction in each group as well as all enroled patients.Results: Overall, 22 (3.7%) out of 595 patients had the recurrent disease during the follow‐up period. The number of metastatic LNs (>5) was only a significant factor for recurrence prediction in all enroled patients (odds ratio: 7.834, p < .001). In the subgroup with ≤5 metastatic LNs, the presence of extrathyroidal extension was only associated with recurrence (odds ratio: 7.333, p = .024) in multivariate analysis. RAI dose was significantly associated with recurrence rate in which the patients with high‐dose RAI (3.7 GBq or higher) had less incidence of recurrence than those with low‐dose RAI (1.11 GBq) in the subgroup with more than five metastatic LNs (odds ratio: 6.533, p = .026).Conclusions: High‐dose RAI (≥3.7 GBq) therapy significantly lowered the recurrence rate in patients with more than five metastatic LNs. Therefore, RAI dose should be determined based on the number of metastatic LNs as well as conventional risk factors.
- 29 June 2021
- Published by Wiley in Clinical Endocrinology
- Vol. 95 (6) , 901-908
Clinical impact of radioactive iodine dose selection based on the number of metastatic lymph nodes in patients with papillary thyroid carcinoma: A multicenter retrospective cohort study
Objective: The aim of this study is to investigate whether the number of metastatic lymph nodes (LNs) could be used as a basis in the radioactive iodine (RAI) dose selection for patients with papillary thyroid carcinoma (PTC).Patients: A total of 595 patients with PTC who received first RAI therapy after total or near‐total thyroidectomy and had no evidence of disease in treatment response assessment were retrospectively enroled from five hospitals. The patients were classified into two subgroups based on the number of metastatic LNs (>5). The multivariate Cox‐proportional hazard model was performed to identify the significant factors for recurrence prediction in each group as well as all enroled patients.Results: Overall, 22 (3.7%) out of 595 patients had the recurrent disease during the follow‐up period. The number of metastatic LNs (>5) was only a significant factor for recurrence prediction in all enroled patients (odds ratio: 7.834, p < .001). In the subgroup with ≤5 metastatic LNs, the presence of extrathyroidal extension was only associated with recurrence (odds ratio: 7.333, p = .024) in multivariate analysis. RAI dose was significantly associated with recurrence rate in which the patients with high‐dose RAI (3.7 GBq or higher) had less incidence of recurrence than those with low‐dose RAI (1.11 GBq) in the subgroup with more than five metastatic LNs (odds ratio: 6.533, p = .026).Conclusions: High‐dose RAI (≥3.7 GBq) therapy significantly lowered the recurrence rate in patients with more than five metastatic LNs. Therefore, RAI dose should be determined based on the number of metastatic LNs as well as conventional risk factors.
- Open Access
- 1 January 2018
- Published by Korean Academy of Rehabilitation Medicine in Annals of Rehabilitation Medicine
- Vol. 42 (1) , 8-17
Crossed Cerebellar Diaschisis: Risk Factors and Correlation to Functional Recovery in Intracerebral Hemorrhage
Sin DS, et al. Ann Rehabil Med. 2018 Feb;42(1):8-17. https://doi.org/10.5535/arm.2018.42.1.8
- 1 January 2018
- Published by Korean Academy of Rehabilitation Medicine in Annals of Rehabilitation Medicine
- Vol. 42 (1) , 8-17
Open AccessCrossed Cerebellar Diaschisis: Risk Factors and Correlation to Functional Recovery in Intracerebral Hemorrhage
Sin DS, et al. Ann Rehabil Med. 2018 Feb;42(1):8-17. https://doi.org/10.5535/arm.2018.42.1.8
- Open Access
- 1 January 2017
- Published by Korean Academy of Rehabilitation Medicine in Annals of Rehabilitation Medicine
- Vol. 41 (6) , 905-914
Neural Correlates of Motor Recovery Measured by SPECT at Six Months After Basal Ganglia Stroke
CVR in the bilateral primary motor cortex and ipsilateral parietal lobe was associated with restoration of upper motor function 6 months after BG stroke. SPECT is a readily available imaging modality useful in studying brain residual function in patients with BG stroke.
- 1 January 2017
- Published by Korean Academy of Rehabilitation Medicine in Annals of Rehabilitation Medicine
- Vol. 41 (6) , 905-914
Open AccessNeural Correlates of Motor Recovery Measured by SPECT at Six Months After Basal Ganglia Stroke
CVR in the bilateral primary motor cortex and ipsilateral parietal lobe was associated with restoration of upper motor function 6 months after BG stroke. SPECT is a readily available imaging modality useful in studying brain residual function in patients with BG stroke.
- 1 September 2014
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 39 (9) , 806-807
Synovial Hemangioma of Hoffa Fat Pad Demonstrated by RBC SPECT/CT
Synovial hemangioma of Hoffa fat pad is an extremely rare disease, which occurs in the knee joints. Because synovial hemangioma often shows nonspecific symptoms, such as pain, swelling, limping, or limitation of motion, diagnosis could be delayed in many cases. We present a 7-year-old boy referred to our department for Tc red blood cell (RBC) scan for the confirmation of hemangioma suggested by the MRI. RBC scan demonstrated intense radioactivity accumulation in Hoffa pad of right knee joint, and subsequent excision biopsy revealed the mass as venous hemangioma.
- 1 September 2014
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 39 (9) , 806-807
Synovial Hemangioma of Hoffa Fat Pad Demonstrated by RBC SPECT/CT
Synovial hemangioma of Hoffa fat pad is an extremely rare disease, which occurs in the knee joints. Because synovial hemangioma often shows nonspecific symptoms, such as pain, swelling, limping, or limitation of motion, diagnosis could be delayed in many cases. We present a 7-year-old boy referred to our department for Tc red blood cell (RBC) scan for the confirmation of hemangioma suggested by the MRI. RBC scan demonstrated intense radioactivity accumulation in Hoffa pad of right knee joint, and subsequent excision biopsy revealed the mass as venous hemangioma.